20 results
DEF 14A
NAMS
NewAmsterdam Pharma Company NV
9 May 24
Definitive proxy
4:15pm
Awards at 2023 Fiscal Year-End
DIRECTOR COMPENSATION
Director Compensation Table
CORPORATE GOVERNANCE
Board Structure
Independence of the Board … Policies
The Audit Committee evaluates the qualifications, independence and performance of the independent auditor as well as pre-approves and reviews
PRE 14A
NAMS
NewAmsterdam Pharma Company NV
29 Apr 24
Preliminary proxy
5:00pm
at 2023 Fiscal Year-End
DIRECTOR COMPENSATION
Director Compensation Table
CORPORATE GOVERNANCE
Board Structure
Independence of the Board of Directors … evaluates the qualifications, independence and performance of the independent auditor as well as pre-approves and reviews the engagement
POS AM
NAMS
NewAmsterdam Pharma Company NV
12 Apr 24
Prospectus update (post-effective amendment)
4:15pm
of the DCGC. The DCGC contains, among other best practice recommendations, certain independence recommendations for the Board of Directors and its
424B3
NAMS
NewAmsterdam Pharma Company NV
12 Mar 24
Prospectus supplement
4:18pm
not comply with
all best practice provisions of the DCGC. The DCGC contains, among other best practice recommendations, certain independence recommendations
POS AM
NAMS
NewAmsterdam Pharma Company NV
28 Feb 24
Prospectus update (post-effective amendment)
5:01pm
, certain independence recommendations for the Board of Directors and its committees. We do not comply with all such recommendations and we will disclose
10-K
r53fexuuqanhi9wayxlm
28 Feb 24
Annual report
8:00am
10-K
EX-4.4
pnwwyejg
28 Feb 24
Annual report
8:00am
424B5
oonzluq3lw
15 Feb 24
Prospectus supplement for primary offering
4:15pm
424B5
isjsmnlmog3wi hrix7
13 Feb 24
Prospectus supplement for primary offering
5:19pm
8-K
tgtm8gb6s52hi
8 Jan 24
NewAmsterdam Pharma Appoints William H. Lewis, J.D., M.B.A. as Chair of its Board of Directors
8:21am
F-3
juh4niuu
7 Dec 23
Shelf registration (foreign)
4:16pm
424B3
qsh 2aao6hg4
15 Aug 23
Prospectus supplement
4:52pm
POS AM
dkf0kfne
7 Aug 23
Prospectus update (post-effective amendment)
7:56am
424B3
ixsrv6n j9az97g9
25 Apr 23
Prospectus supplement
8:14am
POS AM
bpoq u63p
17 Apr 23
Prospectus update (post-effective amendment)
9:09am
F-1
zcrv658
19 Dec 22
Registration statement (foreign)
6:22pm
F-4/A
67c75r
13 Sep 22
Registration of securities (foreign) (amended)
5:03pm
F-4
wzkq7wgcvmq
4 Aug 22
Registration of securities (foreign)
8:02am
- Prev
- 1
- Next